N

NeoPhore Ltd

14 employees

NeoPhore is a provider of novel small molecule therapies intended to treat cancer through stimulation of the immune system.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Immuno-oncology
Therapeutics
Cancer
Translation Service
Drug Discovery
Translational Medicine
Oncology
Genetics
Small Molecule Therapeutics
Simulation

Date founded

2017

Funding rounds raised

Total raised

$21M

from 11 investors over 11 rounds

N

NeoPhore Ltd raised $7.4M on January 19, 2023

Investors: Astellas Venture Capital L.L.C., SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund and Claris Ventures SGR SpA

N

NeoPhore Ltd raised $21M on March 9, 2021

Investors: Astellas Venture Capital L.L.C., SIXTH ELEMENT CAPITAL LLP, 3B Future Health Fund, 2invest financial and Claris Ventures SGR SpA

N

NeoPhore Ltd raised undisclosed on April 27, 2018

Investors: Innovate UK

N

NeoPhore Ltd raised $4M on November 16, 2017

Investors: SIXTH ELEMENT CAPITAL LLP

FAQ